RFK Jr.'s Peptide Plan Explained, Why Most Substances Already Cleared but Few Are Fully Approved

RFK Jr. announced a major peptide reclassification plan in 2026. Here's what's actually cleared and what still needs FDA sign ...
Health AffairsOpinion

Refining FDA’s Plausible Mechanism Framework, Part 2: Manufacturing Challenges, Product Scope, And Post-Approval Considerations

This is part two of a two-part article offering proposals to improve the FDA’s draft guidance to implement a new approval ...

New sunscreen ingredient wins FDA approval after years of delay

A sunscreen ingredient that's been available in Europe, Japan and South Korea for years has finally been approved by the FDA ...
Scientific American

RFK, Jr., puts psychedelics on fast track to FDA review and approval

On Friday the U.S. Food and Drug Administration announced it is fast-tracking the review and approval process for three companies studying psilocybin, the active psychedelic compound in magic ...
Las Vegas Review-Journal

Las Vegas startup aims to cut this lengthy process in half

It takes about 14 years to get a new drug approved by the Food and Drug Administration. That leaves drug companies about six years of exclusive sales until their 20-year patent expires, and they ...